Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
10/13/1994 | WO1994023048A2 Gibbon ape leukemia virus-based retroviral vectors |
10/13/1994 | WO1994023047A1 Biological control agents containing mollusc toxins |
10/13/1994 | WO1994023035A2 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN Phl p II |
10/13/1994 | WO1994023034A2 Variant insulin-like growth factor i receptor subunits and methods for use thereof |
10/13/1994 | WO1994023033A1 Human osteoclast-specific and -related genes |
10/13/1994 | WO1994023032A1 Therapeutic uses of keratinocyte growth factor |
10/13/1994 | WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
10/13/1994 | WO1994023017A1 A composition useful as additive to a cell culture medium, comprising colostrum and serum |
10/13/1994 | WO1994023016A1 Cell matrix stimulated cell attachment and hemidesmosome assembly |
10/13/1994 | WO1994023015A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
10/13/1994 | WO1994023014A1 Tumoricide t lymphocytes |
10/13/1994 | WO1994022914A1 Chimeric cytokine receptors in lymphocytes |
10/13/1994 | WO1994022505A1 Tissue equivalents |
10/13/1994 | WO1994022503A1 Two component fibrin glue |
10/13/1994 | WO1994022489A1 Hybrid genes for use in the production of th-independent cytotoxic t cells |
10/13/1994 | WO1994022486A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides |
10/13/1994 | WO1994022482A1 Compositions including heme-containing proteins and methods relating thereto |
10/13/1994 | WO1994022464A1 Urokinase plasminogen activator fragments |
10/13/1994 | WO1994022463A1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d |
10/13/1994 | WO1994022458A1 Methods for enhancing t-cell effector functions for immunotherapy |
10/13/1994 | WO1994022451A1 Selective regulation of b lymphocyte precursors by hormones |
10/13/1994 | WO1994022286A1 Method of causing somatic hybridization between two species of algae |
10/13/1994 | WO1994017189A3 Protein kinases |
10/13/1994 | WO1994017188A3 Acetyl-coa-carboxylase-gene |
10/13/1994 | WO1994012635A3 Novel seven transmembrane receptors |
10/13/1994 | DE4340129C1 Method for the separation of cellular hybrids by selection using membrane-bound markers |
10/13/1994 | CA2160011A1 Chimeric cytokine receptors in lymphocytes |
10/13/1994 | CA2159898A1 Hybrid genes for use in the production of t h-independent cytotoxic t cells |
10/13/1994 | CA2159637A1 Urokinase plasminogen activator fragments |
10/13/1994 | CA2159595A1 Suppressor of hiv replication and transcription |
10/13/1994 | CA2159471A1 Cell matrix stimulated cell attachment and hemidesmosome assembly |
10/13/1994 | CA2159443A1 Lymphocyte activating agent |
10/13/1994 | CA2159080A1 Human osteoclast-specific and -related genes |
10/13/1994 | CA2158347A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides |
10/13/1994 | CA2136973A1 Recombinant timothy grass pollen allergen ph1 pii |
10/13/1994 | CA2135912A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
10/12/1994 | EP0619373A2 Method for cloning and producing the Bg1II restriction endonuclease and modification methylase |
10/12/1994 | EP0619370A1 Keratinocyte growth factor (KGF) for its use in method of therapeutic treatment for the human or animal body |
10/12/1994 | EP0618976A1 Synthetic dna sequence having enhanced insecticidal activity in maize |
10/12/1994 | EP0618975A1 Dna, dna constructs, cells and plants derived therefrom |
10/12/1994 | EP0618968A1 Tools for the diagnosis and treatment of alzheimer's disease |
10/12/1994 | EP0618967A1 Ifn-gamma antagonist cytokine |
10/12/1994 | EP0618964A1 Novel tissue plasminogen activator variants |
10/12/1994 | EP0618930A1 Monoclonal antibody to hiv-2 and uses thereof |
10/12/1994 | EP0618802A1 Synthetic compounds and compositions with enhanced cell binding |
10/12/1994 | EP0494294B1 Bacterial stress proteins |
10/12/1994 | EP0471011B1 HUMAN LACTOFERRIN cDNA SEQUENCE |
10/12/1994 | CN1093406A Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 |
10/12/1994 | CN1093404A Tumor necrosis factor prepared by utilizing lymphokine to activate killer cells |
10/11/1994 | US5354946 Gene complex particularly useful for modifying plants such as Cucumis melo and Cucumis melo incorporating said gene complex |
10/11/1994 | US5354847 Chimeric antibody with specificity to human tumor antigen |
10/11/1994 | US5354736 Synthetic compounds and compositions with enhanced cell binding |
10/11/1994 | US5354686 Extracellular matrix protein adherent T cells |
10/11/1994 | US5354678 Production of recombinant adeno-associated virus vectors |
10/11/1994 | US5354665 Recombinant DNA processes for producing PI-linked lymphocyte function associated antigen-3 |
10/11/1994 | US5354661 Monoclonal antibody to enterohemorrhagic Escherichia coli 0157:H7 and 026:H11 and method for detection |
10/11/1994 | CA1332367C Method for the reduction of heterogeneity of monoclonal antibodies |
10/06/1994 | DE4410136A1 Tumoricidal T lymphocytes |
10/05/1994 | EP0618293A1 Human contactin, a cell adhesion molecule |
10/05/1994 | EP0618292A1 CEA derivatives lacking the Hydrophobic C-terminal domain |
10/05/1994 | EP0618220A1 Method for purifying interleukin-4 |
10/05/1994 | EP0617736A1 USE OF $i(BACILLUS THURINGIENSIS) ISOLATES FOR CONTROLLING PESTS IN THE FAMILY APHIDIDAE |
10/05/1994 | EP0602044A4 A cdna clone encoding a human norepineprhine transporter. |
10/05/1994 | EP0576590A4 Response element compositions and assays employing same |
10/05/1994 | EP0434809B1 Method for detecting cirrhosis of the liver |
10/04/1994 | US5352775 Diagnosis, therapy cancer |
10/04/1994 | US5352668 Product and method for improving keratinocyte adhesion to the dermis |
10/04/1994 | US5352664 Thrombin derived polypeptides; compositions and methods for use |
10/04/1994 | US5352587 Genetic engineering |
10/04/1994 | US5352584 Radioimmunoassay or enzyme-linked immunosorbent assay for qunatitative analysis |
10/04/1994 | US5352440 Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof |
09/30/1994 | WO1993019172A1 Methods for producing members of specific binding pairs |
09/30/1994 | CA2131151A1 Methods for producing members of specific binding pairs |
09/29/1994 | WO1994022014A1 Parvovirus receptors and methods of use |
09/29/1994 | WO1994021814A1 Antibodies and assays for determining mutations in the apc gene |
09/29/1994 | WO1994021813A1 Monoclonal antibodies specific for fibroblast growth factor receptors, immunotoxins, and use thereof |
09/29/1994 | WO1994021812A2 Hepatitis b escape mutant specific binding molecules |
09/29/1994 | WO1994021808A1 Process for preparing cancer vaccines |
09/29/1994 | WO1994021806A1 Delivery system controlled through factors associated with hiv and cell |
09/29/1994 | WO1994021799A1 USE OF PORCINE GAL α(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES |
09/29/1994 | WO1994021798A1 Stimulation of immune response by viral protein |
09/29/1994 | WO1994021795A1 Novel pesticidal proteins and strains |
09/29/1994 | WO1994021794A1 Dna, dna constructs, cells and plants derived therefrom |
09/29/1994 | WO1994021792A2 Inhibition of selected tumor growth with recombinant viral vectors |
09/29/1994 | WO1994021787A1 Method for defined deletions of dna |
09/29/1994 | WO1994021784A1 Stromelysin-1 deficient transgenic mice |
09/29/1994 | WO1994021781A2 Extracellular signal-regulated kinase, sequences, and methods of production and use |
09/29/1994 | WO1994021687A1 A method of detecting rupture of the amniotic membranes in pregant mammals |
09/29/1994 | WO1994021681A1 Growth differentiation factor-8 |
09/29/1994 | WO1994021680A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
09/29/1994 | WO1994021679A1 Inhibitor of vascular endothelial cell growth factor |
09/29/1994 | WO1994021672A1 Novel antimicrobial peptides from bovine neutrophils |
09/29/1994 | WO1994021660A1 Cloned human alpha1c adrenergic receptor |
09/29/1994 | WO1994021291A1 Chlamydia vaccine and process |
09/29/1994 | WO1994021287A1 Peptide coated dendritic cells as immunogens |
09/29/1994 | WO1994021126A1 Nucleic acid coding for a tumor rejection antigen precursor |
09/29/1994 | WO1994021117A1 Method and apparatus for encapsulation of biologically-active substances in cells |
09/29/1994 | WO1994021115A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
09/29/1994 | WO1994016094A3 Recombinant anti-vla4 antibody molecules |
09/29/1994 | WO1994013800A3 Mk protein preparation and use in cell culture |